Dr. Mathias Uhlén is a Co-Founder and serves as Board Member at Atlas Antibodies. He is a Co-Founder and serves as Deputy Chairman & Scientific Advisor at Affibody. He served as Board Member at Bure Equity. He serves as Professor at the Royal Institute of Technology. He serves as a Board Member at SweTree Technologies and Affibody. He is a Professor of Microbiology at the Royal Institute of Technology, Stockholm, Sweden. He is a member of the Royal Swedish Academy of Engineering Science (IVA) and he is also a member of the Royal Swedish Academy of Science. He also serves as Board Member at Bure Equity. He is a Board Member & Member of the Innovation Committee at Novozymes.